Page last updated: 2024-10-26

dimaprit and Glial Cell Tumors

dimaprit has been researched along with Glial Cell Tumors in 2 studies

Dimaprit: A histamine H2 receptor agonist that is often used to study the activity of histamine and its receptors.

Research Excerpts

ExcerptRelevanceReference
"Gliomas are diagnosed and staged by conventional MRI."2.66The role of APT imaging in gliomas grading: A systematic review and meta-analysis. ( Demetriou, E; Sotirios, B; Topriceanu, CC; Zakrzewska, Z, 2020)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Sotirios, B1
Demetriou, E1
Topriceanu, CC1
Zakrzewska, Z1
Zhang, XY1
Zhai, Y1
Jin, Z1
Li, C1
Sun, PZ1
Wu, Y1

Reviews

1 review available for dimaprit and Glial Cell Tumors

ArticleYear
The role of APT imaging in gliomas grading: A systematic review and meta-analysis.
    European journal of radiology, 2020, Volume: 133

    Topics: Amides; Brain Neoplasms; Dimaprit; Glioma; Humans; Magnetic Resonance Imaging; Neoplasm Grading; Pro

2020

Other Studies

1 other study available for dimaprit and Glial Cell Tumors

ArticleYear
Preliminary demonstration of in vivo quasi-steady-state CEST postprocessing-Correction of saturation time and relaxation delay for robust quantification of tumor MT and APT effects.
    Magnetic resonance in medicine, 2021, Volume: 86, Issue:2

    Topics: Algorithms; Animals; Dimaprit; Glioma; Magnetic Resonance Imaging; Protons; Rats; Tumor Microenviron

2021